BRIDGER; Gary J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for BRIDGER; Gary J..The latest application filed is for "use of cxcr4 antagonists".
Company Profile
3.25.40
- BRIDGER; Gary J. - Bellingham WA
- BRIDGER; Gary J. - Bridgewater NJ
- BRIDGER; Gary J. - Cambridge MA
- Bridger; Gary J. - Bryn Mawr PA
- Bridger; Gary J. - West Chester PA
Patent Activity
| Patent | Date |
|---|---|
| Use Of Cxcr4 Antagonists App 20210161859 - DALE; David C. ; et al. | 2021-06-03 |
| Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy App 20200000774 - Bridger; Gary J. ; et al. | 2020-01-02 |
| Methods To Mobilize Progenitor/stem Cells App 20190216773 - BRIDGER; Gary J. ; et al. | 2019-07-18 |
| Chemokine receptor binding heterocyclic compounds with enhanced efficacy Grant 10,322,111 - Bridger , et al. | 2019-06-18 |
| Methods To Mobilize Progenitor/stem Cells App 20170049747 - BRIDGER; Gary J. ; et al. | 2017-02-23 |
| Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy App 20160228413 - BRIDGER; Gary J. ; et al. | 2016-08-11 |
| Methods To Mobilize Progenitor/stem Cells App 20150246019 - BRIDGER; Gary J. ; et al. | 2015-09-03 |
| Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy App 20150038509 - Bridger; Gary J. ; et al. | 2015-02-05 |
| Use of CXCR4 Antagonists App 20150030561 - Dale; David C. ; et al. | 2015-01-29 |
| Methods To Mobilize Progenitor/stem Cells App 20130273009 - Bridger; Gary J. ; et al. | 2013-10-17 |
| Methods For Increasing Blood Flow And/Or Promoting Tissue Regeneration App 20130095076 - BRIDGER; Gary J. ; et al. | 2013-04-18 |
| Methods To Mobilize Progenitor/stem Cells App 20110129448 - BRIDGER; Gary J. ; et al. | 2011-06-02 |
| Methods to mobilize progenitor/stem cells Grant 7,935,692 - Bridger , et al. May 3, 2 | 2011-05-03 |
| Methods to mobilize progenitor/stem cells Grant 7,897,590 - Bridger , et al. March 1, 2 | 2011-03-01 |
| Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity Grant RE42,152 - Bridger , et al. February 15, 2 | 2011-02-15 |
| CXCR4 chemokine receptor binding compounds Grant 7,863,293 - Bridger , et al. January 4, 2 | 2011-01-04 |
| Combination Therapy App 20100178271 - Bridger; Gary J. ; et al. | 2010-07-15 |
| CXCR4 antagonists Grant 7,709,486 - Bridger , et al. May 4, 2 | 2010-05-04 |
| Chemokine Receptor Binding Heterocyclic Compounds App 20100105915 - BRIDGER; Gary J. ; et al. | 2010-04-29 |
| Methods For Increasing Blood Flow And/or Promoting Tissue Regeneration App 20100035941 - Bridger; Gary J. ; et al. | 2010-02-11 |
| Combination Therapy App 20100003224 - Bridger; Gary J. ; et al. | 2010-01-07 |
| Chemokine receptor binding heterocyclic compounds Grant 7,629,337 - Bridger , et al. December 8, 2 | 2009-12-08 |
| Chemokine Receptor Binding Heterocyclic Compounds With Enhanced Efficacy App 20090281308 - BRIDGER; Gary J. ; et al. | 2009-11-12 |
| Chemokine receptor binding heterocyclic compounds with enhanced efficacy Grant 7,550,484 - Bridger , et al. June 23, 2 | 2009-06-23 |
| Chemokine receptor binding compounds Grant 7,498,346 - Zhou , et al. March 3, 2 | 2009-03-03 |
| Chemokine receptor binding compounds Grant 7,491,735 - Zhou , et al. February 17, 2 | 2009-02-17 |
| Cxcr4 Antagonists App 20080287454 - BRIDGER; Gary J. ; et al. | 2008-11-20 |
| Synthesis of enantiomerically pure amino-substituted fused bicyclic rings Grant 7,452,994 - McEachern , et al. November 18, 2 | 2008-11-18 |
| Cxcr4 Chemokine Receptor Binding Compounds App 20080255197 - BRIDGER; Gary J. ; et al. | 2008-10-16 |
| Methods to modulate conditions mediated by the CXCR4 receptor Grant 7,414,065 - Bridger , et al. August 19, 2 | 2008-08-19 |
| Chemokine receptor binding heterocyclic compounds with enhanced efficacy Grant 7,354,934 - Bridger , et al. April 8, 2 | 2008-04-08 |
| Methods To Mobilize Progenitor/stem Cells App 20080063624 - Bridger; Gary J. ; et al. | 2008-03-13 |
| CXCR4 chemokine receptor binding compounds Grant 7,291,631 - Bridger , et al. November 6, 2 | 2007-11-06 |
| Use Of Rare Earth Compounds For The Prevention Of Kidney Stone Disease App 20070116782 - Abrams; Michael J. ; et al. | 2007-05-24 |
| Chemokine receptor binding compounds App 20070066624 - Zhou; Yuanxi ; et al. | 2007-03-22 |
| Use of rare earth compounds for the prevention of kidney stone disease Grant 7,192,609 - Abrams , et al. March 20, 2 | 2007-03-20 |
| Synthesis of enantiomerically pure amino-substituted fused bicyclic rings App 20070060757 - McEachern; Ernest J. ; et al. | 2007-03-15 |
| Chemokine receptor binding heterocyclic compounds Grant 7,183,273 - Bridger , et al. February 27, 2 | 2007-02-27 |
| Methods to enhance chemotherapy App 20070043012 - Bridger; Gary J. | 2007-02-22 |
| Chemokine receptor binding heterocyclic compounds App 20060264434 - Bridger; Gary J. ; et al. | 2006-11-23 |
| Synthesis of enantiomerically pure amino-substituted fused bicyclic rings Grant 7,135,570 - McEachern , et al. November 14, 2 | 2006-11-14 |
| Methods to mobilize progenitor/stem cells App 20060223180 - Bridger; Gary J. ; et al. | 2006-10-05 |
| Compositions and methods for treating tissue ischemia App 20060194776 - Losordo; Douglas W. ; et al. | 2006-08-31 |
| Methods to mobilize progenitor/stem cells App 20060193826 - Bridger; Gary J. ; et al. | 2006-08-31 |
| Chemokine combinations to mobilize progenitor/stem cells App 20060035829 - Bridger; Gary J. ; et al. | 2006-02-16 |
| Methods to mobilize progenitor/stem cells Grant 6,987,102 - Bridger , et al. January 17, 2 | 2006-01-17 |
| Chemokine receptor binding compounds App 20050277668 - Zhou, Yuanxi ; et al. | 2005-12-15 |
| Chemokine receptor binding compounds App 20050277670 - Zhou, Yuanxi ; et al. | 2005-12-15 |
| Synthesis of enantiomerically pure amino-substituted fused bicyclic rings App 20050080267 - McEachern, Ernest J. ; et al. | 2005-04-14 |
| Chemokine receptor binding heterocyclic compounds with enhanced efficacy App 20050059702 - Bridger, Gary J. ; et al. | 2005-03-17 |
| Synthesis of enantiomerically pure amino-substituted fused bicyclic rings Grant 6,825,351 - McEachern , et al. November 30, 2 | 2004-11-30 |
| Chemokine receptor binding heterocyclic compounds App 20040235823 - Bridger, Gary J. ; et al. | 2004-11-25 |
| Methods to mobilize progenitor/stem cells App 20030130250 - Bridger, Gary J. ; et al. | 2003-07-10 |
| Synthesis of enantiomerically pure amino-substituted fused bicyclic rings App 20030114679 - McEachern, Ernest J. ; et al. | 2003-06-19 |
| Use of nitric oxide scavengers to modulate inflammation and matrix metalloproteinase activity App 20020193363 - Bridger, Gary J. ; et al. | 2002-12-19 |
| Use of rare earth compounds for the prevention of kidney stone disease App 20020155168 - Abrams, Michael J. ; et al. | 2002-10-24 |
| Pharmaceutical compositions comprising metal complexes App 20020049190 - Bridger, Gary J. ; et al. | 2002-04-25 |
| Antiviral compounds Grant 5,817,807 - Bridger , et al. October 6, 1 | 1998-10-06 |
| Labeled chemotactic peptides to image focal sites of infection or inflammation Grant 5,792,444 - Fischman , et al. August 11, 1 | 1998-08-11 |
| Cyclic polyamines Grant 5,698,546 - Bridger , et al. December 16, 1 | 1997-12-16 |
| Molecule labelling using 2-hydraninopyridine derivatives Grant 5,679,778 - Abrams , et al. October 21, 1 | 1997-10-21 |
| Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity Grant 5,583,131 - Bridger , et al. December 10, 1 | 1996-12-10 |
| Complexes with .sup.99m Tc suitable for radiolabelling monoclonal antibodies or other macro molecules Grant 5,350,837 - Bridger , et al. September 27, 1 | 1994-09-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 